CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
CGT Global Attends Advanced Therapies USA 2024 to Support Cell and Gene Therapy Innovation
CGT Global’s Cate Spears and Eliona Kola attend Advanced Therapies USA 2024, engaging with industry leaders to advance cell and gene therapy innovation. Attending Advanced Therapies USA is a valuable opportunity to engage with global leaders and drive innovation in cell and gene therapy.”— Cate Spears, CEO of CGT Global, FOLSOM, CA, UNITED STATES, November 12, 2024 /EINPresswire.com/ — CEO Cate Spears and Process Development Scientist Eliona Kola to Attend Premier Industry Event CGT Global, a leader in cell and gene therapy…
Read More
Protected: Optimizing Engraftment Rates for Researchers in Cord Blood and PBMNC Studies
There is no excerpt because this is a protected post.
Read More
EIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures
CGT Global, a leading Contract Research Organization (CRO) & biotech manufacturer announced approval to provide disease state leukopaks to researchers worldwide FOLSOM, CALIFORNIA, UNITED STATES, June 11, 2024 /EINPresswire.com/ — CGT Global, a leading international Contract Research Organization (CRO) and biotech manufacturer, announced today it has received approval from Western Copernus Group (WCG) to provide disease state leukopaks to researchers in the US and worldwide. WCG is an independent Institutional Review Board (IRB) made up of 200 experts that are augmented by one of the…
Read More
EIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures
CGT Global, leader in human cell collection, partners with Austin Financial Services to expedite cell & gene therapy research for life-threatening conditions. FOLSOM, CALIFORNIA, USA, March 20, 2024 /EINPresswire.com/ — A world leader in human cell collection and manufacturing, CGT Global announced today it is partnering with Austin Financial Services, Inc., a leading national middle market working capital lender based in Los Angeles, to expand its programs and services expediting cell and gene research assisting hospitals and scientific experts in moving lifesaving…
Read More
EIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States
FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has 60 cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global was selected to become an exclusive partner in the United States due to its extensive cell isolation expertise and expansive healthcare partnerships. “The missions of the two…
Read More
KFBK & NPR Interviews with CGT Global
THE FUTURE OF HEALTHCARE Our own Cate Spears, CEO and founder of CGT Global, was just interviewed on two major news media outlets. Nationally recognized broadcaster Cristina Mendosa from KFBK and Vicki Gonzales from NPR‘s CapRadio. Both interviews discuss our innovative collaboration to deliver cell and gene therapies across the globe. LISTEN NOW We encourage you to listen and share both interviews below.
Read More
Top-Tier Quality
TOP-TIER QUALITY Biotechnology is a rapidly evolving industry which has the potential to revolutionize the Healthcare field. As the biotechnology industry continues to advance ensuring the safety, efficacy and quality of the products and processes are maintained at every step becomes critical to everyone in the field. This is where CGT Global plays a pivotal role. CGT Global has become a trusted partner for biotech companies around the world. At CGT Global, Quality Assurance and Compliance are cornerstones in delivering top-tier products…
Read More
Partnership Newsflash
CGT GLOBAL SELECTED AS STRATEGIC PARTNER TO EXPAND CELL AND GENE THERAPIES ACROSS THE UNITED STATES CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global was selected to become an exclusive partner in the United States due to its extensive cell isolation expertise and expansive…
Read More
Meet our Laboratory Team
CGT Global is thrilled to introduce you to the incredible members of our laboratory team who make the magic happen every day. Bryan: The Fearless Leader With an analytical mind and a passion for innovation, Bryan spearheads our lab projects, ensuring precision and excellence in every isolation and custom project. Eliona: The Hotshot Scientist Eliona’s infectious energy and positivity light up our lab. Her dedication to detail and constant curiosity makes her essential to our success. Marcus: The Next In Line…
Read More
Webinar: Access to Cell and Gene Therapies
Addressing Disparities in Access to Cell and Gene Therapies We are thrilled to share the fantastic outcome of our recent webinar, ” Addressing Disparities in Access to Cell and Gene Therapies.” The engagement and insightful discussions during the session were truly remarkable, and we want to extend our heartfelt gratitude to all who participated. Missed the Webinar? No Worries! For those unable to join us live, we’ve got great news! We understand that life can get busy, and schedules can be demanding.…
Read More
New Discovery of 60 Genetic Mutations
Holy DNA! Scientists have just uncovered 60 new genetic diseases that hadn’t been discovered before! It’s like finding a whole bunch of new Pokémon, except these new discoveries are going to have a real impact on the lives of thousands of families.
So here’s the scoop: these scientists analyzed the DNA of over 13,500 people who had previously been struggling with undiagnosed developmental delays or intellectual disabilities. They used a fancy technique called exome sequencing, which basically reads the important parts of your DNA that make proteins. By comparing the DNA of these individuals to a reference genome, the researchers were able to spot mutations or variations that were unique to the affected individuals.
Read More
CGT Global introduces Clinical Commercial Solutions Guide including Clinical Donor Screening
StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening By StemExpress January 16, 2023 StemExpress has published its full Clinical Commercial Solutions Guide and launched their new Clinical Donor Screening services. Now, researchers and therapeutic developers can discover how StemExpress is utilizing a nationwide & coast-to-coast footprint of privately owned and operated collection facilities to support the cell and gene therapy market with GMP-compliant leukapheresis and more. As more cellular therapy candidates move through IND into Phase I and beyond, there is a…
Read More